Details about Pierre Johansen

Access statistics for papers by Pierre Johansen.

Last updated 2024-03-09. Update your information in the RePEc Author Service.

Short-id: pjo381

Journal Articles

2022

1. The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
   PharmacoEconomics, 2022, 40, (8), 751-776

2021

2. Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions”
   PharmacoEconomics, 2021, 39, (1), 137-138

2020

3. Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM
   PharmacoEconomics, 2020, 38, (9), 953-969 View citations (1)
4. External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions
   PharmacoEconomics, 2020, 38, (10), 1123-1133 View citations (1)
5. Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements
   PharmacoEconomics, 2020, 38, (5), 485-497 View citations (1)

2019

6. Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
   PharmacoEconomics - Open, 2019, 3, (4), 537-550 View citations (1)

2017

7. Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)
   PharmacoEconomics, 2017, 35, (3), 375-396 View citations (6)

2014

8. Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations
   PLOS ONE, 2014, 9, (10), 1-12 View citations (6)